ArticleVeterinary research communications2022
Estimating the production losses due to cystic echinococcosis in water buffaloes (Bubalus bubalis) in Turkey.
Article in Veterinary research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Community knowledge, attitudes and practices related to cystic echinococcosis in Ethiopia: Implications for control.One health (Amsterdam, Netherlands) · 2026Article
- Benefits of public awareness in mitigating cystic echinococcosis risk in Western China: A climate and socio-economic perspective.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study aimed at estimating the direct (condemned offal) and indirect (meat, milk, and fecundity losses) production losses due to cystic echinococcosis (CE) in water buffaloes in Turkey. A spreadsheet loss model was constructed, and the mean prevalence ratio of CE was accepted as 3.8% in male and 21.7% in female buffaloes. The annual financial losses were estimated with official and previously published data under expected (mean value), optimistic (lowered by 10%), and pessimistic (increased by 10%) scenarios with the prices current in 2021. The production losses in an infected male and female water buffalo were estimated at $54.5 ($49.1-59.9) and $89.9 ($80.9-98.9), respectively. Due to CE, the nationwide annual total production losses were estimated at $1.5 million ($1.3-1.6) for water buffaloes in Turkey. In conclusion, farmers, policymakers, and the public need to be informed about CE's risks and financial impact. Control/eradication programs should be included in government policies at the national level after a cost/benefit analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.